Some years ago, glycosyl derivatives of kanatnycin A (KMA) were obtained enzymatically by ENDo et al.') and chemically by PERLMAN et al.'" Although their chemical and biological properties were partially described, their precise chemical properties and antibacterial activities against drug-resistant bacteria producing specific aminoglucosides-inactivating enzymes were not mentioned.
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In this study, we have prepared new reduced types of KMAglucosides and their chemical and microbiological properties have been investigated. At first, we tried to prepare the enzymatically-derived compounds by the method of ENDO et a1.". Utilizing the identical method, we prepared the glucosyl derivative of KMA by transglucosylase activity of ClaraseR. We detected a glucosyl derivative possessing the same properties as described by them. However, this compound could not be regarded as the O-glucoside, reported in the case of neamine", because analysis in high-voltage paper electrophoresis (pH 1.8, 220 volts/cm, about 40 mA/cm, for 30 minutes, with Model HV 5000-3 of Savant Instruments, Inc.) and in silica gel thin-layer chromatography (using CHC13 -MeOH -NH4OH, 1:3:2), show- The material prepared by the method described in the text was applied to CG-50 column equilibrated with 0.02 N NH4OH. Elution was carried out with 1,000 ml of linear gradient of 0.02 -1.0 N NH4OH. Antibacterial activity (Diameter of inhibitory zone, mm) was determined bioautographically by paper-disk method.
Fraction number THE JOURNAL OF ANTIBIOTICS JULY 1979 NaBH,, the pH of the solution was adjusted to pH 2.0 with HCl and after standing for 15 minutes at room temperature, 300 ml of MeOH was added slowly to the solution. The resulting precipitate was separated from the solution by filtration and dissolved again in 50 ml of distilled water.
After adjustment of the pH to 8 with NaOH, the solution was then passed through Amberlite CG-50 resin (NH,+ cycle, 2.0 x 18 cm) and eluted with 1,000 ml of gradient of 0.02' 1.0 N NH,OH.
By bioautography using paperdiscs, we observed mainly three fractions possessing antibacterial activity against Escherichia coli K-12 NIHJ as shown in Fig. 1 . Using kanamycinresistant strain, E. coli HL97/W677 as test organism inactivating KMA by 6'-N-acetylation, only fraction P-I possessed antibacterial components.
In a similar manner, only fraction P-II was active against E. coli K-12 ML1629 that inactivates KMA by 3'-O-phosphorylation''6'.
The peak possessing the highest activity against E. coli K-12 NIHJ was identified as unreacted KMA by highvoltage paper electrophoresis and thin-layer chromatography.
The respective fractions of P-I and P-11 were pooled and after the lyophilization, the crude materials were dissolved in distilled water and purified by rechromatography on spots were compared with those derived from KMA. In the case of P-I, a new ninhydrin positive and periodate-sensitive spot having Rf 0.18 was detected with simultaneous loss of the spot (Rf 0.39) originating from 6-amino-6-deoxyglucose in KMA. On the other hand, from P-II, a new spot having Rf 0.15 was demonstrated along with the disappearance of the spot (Rf 0.26) derived from 2-deoxystreptamine. This new spot was also sensitized with ninhydrin and periodate treatments. Analysis of P-I and P-II gave C 43.76%, N 8.54% and C 45.63%, N 8.37% respectively. The C/N ratio of 5.12 and 5.42 were close to the C/N ratio of 5.14 expected for the case of glucose to KMA, 1: 1.
These results suggested that P-I were modified by one mole of glucose at the moiety of 6-amino-6-deoxyglucose and P-II was modified at the for 3-NH2 group of 2-deoxystreptamine in KMA respectively. Postulation might be permissible that P-I is polyhydroxy-alkylated derivative of KMA modified at 6-NH2 group of 6-amino-6-deoxyglucose and P-II was modified one at either the ]-or 3-NH2 group of 2-deoxystreptamine.
Antibacterial activity of P-I and P-11 was compared with KMA, dibekacin (DKB) and gentamicin C complex (GMCx) against some aminoglycosides-resistant strains known to produce specific inactivating enzyme. Minimal inhibitory concentration (MIC) was determined after incubation for 18 hours by standard serial two-fold dilution method using Heart infusion agar (Eiken Chemical Co., Ltd.) as follows. One loopful of 108 cells/ml grown in Tryptosoya broth (Nissui Pharmaceutical Co., Ltd.) was inoculated onto agar-plates. As presented in Table 1 , compared with KMA, P-I had an improved potency against E. coli HL97/W677 and E. coli R5/W677 both possessing 6'-N-acetyltransferase but had lower activity against almost all the sensitive strains. P-11 had considerably low level of MIC (6.25 jug/ml) against E. coli LA290/R55 producing 2"-O-adenylyltransferase responsible for KMA-, DKB-and GMCx-resistance. P-11 was more effective than KMA and P-I against E. coli K-12 ML1629 encoding 3'-O-phosphoryl transferase and Ps. aeruginosa 130 and Ps. aeruginosa 39 both producing 3-N-acetyltransferase but the activity of P-II was lower than DKB. Against another sensitive strains, P-II had also lesser inhibitory effects than KMA as well as DKB or GMCx.
Antibacterial spectra of P-I and P-II also indicate that the former was modified at 6'-NH2 group of 6-deoxy-6-amino-glucose moiety and the latter was probably at 1-NHz group of 2-deoxystreptamine moiety like amikacin (BB-K8)1). The identification of the absolute structure of these has been now undertaken.
